|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/20/24 Future Health ESG Corp. 10-K 12/31/23 55:5.6M Toppan Merrill/FA2 |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.62M
2: EX-10.19 Material Contract HTML 116K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 22K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 22K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 19K
12: R1 Document and Entity Information HTML 100K
13: R2 Balance Sheets HTML 99K
14: R3 Balance Sheets (Parenthetical) HTML 50K
15: R4 Statements of Operations HTML 72K
16: R5 Statements of Changes in Stockholders' Deficit HTML 54K
17: R6 Statements of Cash Flows HTML 77K
18: R7 Description of Organization and Business HTML 48K
Operations
19: R8 Summary of Significant Accounting Policies HTML 77K
20: R9 Public Offering HTML 20K
21: R10 Related Party Transactions HTML 29K
22: R11 Commitments and Contingencies HTML 28K
23: R12 Stockholders' Deficit HTML 36K
24: R13 Income Tax HTML 66K
25: R14 Subsequent Events HTML 26K
26: R15 Summary of Significant Accounting Policies HTML 104K
(Policies)
27: R16 Summary of Significant Accounting Policies HTML 57K
(Tables)
28: R17 Income Tax (Tables) HTML 66K
29: R18 Description of Organization and Business HTML 124K
Operations (Details)
30: R19 Summary of Significant Accounting Policies HTML 52K
(Details)
31: R20 Summary of Significant Accounting Policies - Basic HTML 47K
and diluted net income (Loss) Per Common Share
(Details)
32: R21 Summary of Significant Accounting Policies - HTML 27K
Reconciled of common stock reflected in the
balance sheets (Details)
33: R22 Public Offering (Details) HTML 46K
34: R23 Related Party Transactions - Founder Shares HTML 60K
(Details)
35: R24 Related Party Transactions - Related Party Loans HTML 29K
(Details)
36: R25 Related Party Transactions - Additional HTML 46K
information (Details)
37: R26 Commitments and Contingencies - Underwriting HTML 33K
Agreement and Advisory Fees (Details)
38: R27 Commitments and Contingencies - Special Warrant HTML 33K
Agreement (Details)
39: R28 Commitments and Contingencies - Non-Redemption HTML 38K
Agreement (Details)
40: R29 Stockholders' Deficit - Preferred Stock (Details) HTML 27K
41: R30 Stockholders' Deficit - Common Stock (Details) HTML 46K
42: R31 Stockholders' Deficit - Warrants (Details) HTML 53K
43: R32 Stockholders' Deficit - Non-Redemption Warrants HTML 23K
(Details)
44: R33 Income Tax - Deferred tax (Details) HTML 22K
45: R34 Income Tax - Provision for Income Tax (Details) HTML 28K
46: R35 Income Tax (Details) HTML 20K
47: R36 Income Tax - Effective Tax Rate Reconciliation HTML 26K
(Details)
48: R37 Subsequent Events (Details) HTML 91K
49: R38 Pay vs Performance Disclosure HTML 29K
50: R39 Insider Trading Arrangements HTML 23K
52: XML IDEA XML File -- Filing Summary XML 92K
55: XML XBRL Instance -- fhltu-20231231x10k_htm XML 820K
51: EXCEL IDEA Workbook of Financial Report Info XLSX 109K
8: EX-101.CAL XBRL Calculations -- fhltu-20231231_cal XML 71K
9: EX-101.DEF XBRL Definitions -- fhltu-20231231_def XML 519K
10: EX-101.LAB XBRL Labels -- fhltu-20231231_lab XML 917K
11: EX-101.PRE XBRL Presentations -- fhltu-20231231_pre XML 721K
7: EX-101.SCH XBRL Schema -- fhltu-20231231 XSD 152K
53: JSON XBRL Instance as JSON Data -- MetaLinks 344± 515K
54: ZIP XBRL Zipped Folder -- 0001410578-24-000237-xbrl Zip 376K
Exhibit 31.2
CERTIFICATIONS
I, Travis A. Morgan, certify that:
1.I have reviewed this Annual Report on Form 10-K of Future Health ESG Corp.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313); |
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| | |
Date: March 19, 2024 | By: | /s/ Travis A. Morgan |
| | |
| | Chief Financial Officer |
| | (Principal Financial Officer) |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 3/20/24 | None on these Dates | ||
| Filed on: | 3/19/24 | |||
| For Period end: | 12/31/23 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/06/24 Future Health ESG Corp. 8-K:1,9 3/05/24 14:395K Toppan Merrill/FA 2/23/24 Future Health ESG Corp. 8-K:1,5,9 2/15/24 13:393K Toppan Merrill/FA 1/30/24 Future Health ESG Corp. 8-K:1,2,9 1/29/24 12:274K Toppan Merrill/FA 1/04/24 Future Health ESG Corp. 8-K:1,5,9 12/28/23 13:337K Toppan Merrill/FA 9/21/23 Future Health ESG Corp. 8-K:1,8,9 9/15/23 12:264K Toppan Merrill/FA 3/29/23 Future Health ESG Corp. 8-K:1,9 3/28/23 12:341K Toppan Merrill/FA 3/09/23 Future Health ESG Corp. 10-K 12/31/22 51:5M Toppan Merrill/FA2 11/18/22 Future Health ESG Corp. 8-K:4,9 11/15/22 12:256K Toppan Merrill/FA 9/14/21 Future Health ESG Corp. 8-K:1,3,5,8 9/09/21 16:1.4M Toppan Merrill/FA 9/01/21 Future Health ESG Corp. S-1/A 8/31/21 25:3M Toppan Merrill/FA |